Martin Noel

Martin Noel has a diverse work experience, starting in 2005. Martin worked at Boston Scientific as a Co-investigator for the Bi-Ventricular Capture Verification Study from 2005 to 2007. At AstraZeneca, they served as a Medical Science Liaison from 2009 to 2012, where they developed relationships with Key Opinion Leaders and provided technical training to field sales. From 2012 to 2015, Martin worked at Baxter International Inc. as a Medical Science Liaison. Martin then joined Baxalta as a Global Medical Affairs and Medical Advisor from 2015 to 2016. Martin also worked at Shire as a Medical Advisor in the Baxalta division from 2016 to 2017. Martin was a part-time professor at the University of Ottawa Office of Continuing Medical Education from an unspecified start date in 2010 to 2017. Martin held the role of Medical Advisor at Bristol-Myers Squibb from 2017 to 2018 and as a Medical Advisor at Novartis from 2018 to 2018. Martin'smost recent position was at Paladin Labs as an Associate Director of Business Development from 2019 to April 2023. Currently, Martin is the Chief Medical Officer and BD at Lixa, where they are responsible for implementing the company's vision and managing clinical development programs in infectious diseases.

Martin Noel's education history begins with their Master of Health Administration (MHA) degree, which they pursued at the Telfer School of Management at the University of Ottawa starting in 2014. Prior to that, they obtained a Post-doctoral degree in Epidemiology/Public Health from Université Laval, where they studied from 2006 to 2009. Before their post-doctoral studies, Martin pursued their Doctor of Philosophy (Ph.D.) in Cardiovascular Rehabilitation at Université Laval from 2002 to 2006. Martin'seducational journey commenced with a Master of Science (M.Sc.) degree in Exercise Physiology from the same university, which they completed from 1999 to 2002.

In addition to their formal education, Martin has obtained various certifications. Martin completed the "Adding Value through Diversity" course offered by LinkedIn in July 2022. Earlier, in April 2021, they participated in "The Pharma Forecasting Course - with Gary Johnson" and "Pharma-Biotech Product and Company Valuation - with Dr Patrik Frei" courses, both conducted by CELforPharma. Lastly, Martin holds the certification of "Exercise Specialist" from the American College of Sport Medicine, although the exact month and year of acquisition are not specified.